Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer;”
Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
ClinicalTrials.gov study NCT00601848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00867009. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03999710. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03906071. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04822298. IPD Sharing: YES. Countries: 3. Publications: 0.
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00109876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy
ClinicalTrials.gov study NCT00100932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00660816. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01731587. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
ClinicalTrials.gov study NCT00365547. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study
ClinicalTrials.gov study NCT00745875. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00559897. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
ClinicalTrials.gov study NCT03337698. IPD Sharing: YES. Countries: 7. Publications: 0.
Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging
ClinicalTrials.gov study NCT05254132. IPD Sharing: UNDECIDED. Countries: 0. Publications: 9.
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03559049. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations
ClinicalTrials.gov study NCT02450591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00995761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosin
ClinicalTrials.gov study NCT02271139. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00862134. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02507375. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.